Persistent Asset Partners Ltd

Position in CAPR — Capricor Therapeutics, Inc.

CIK 2056052 HONG KONG, K3

Back to CAPR Full portfolio

Position in CAPR

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

-$605,963 QoQ

Shares Held

-100.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2024

4 quarters on record

Common Shares in CAPR Over Time

Shares Held

Position Value (USD)

Derivatives in CAPR

reported options exposure · as of Jun 30, 2026

CallValue

$20,010

CallShares

831

PutValue

$32,652

PutShares

1,356

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Persistent Asset Partners Ltd holds $74,585,923 across 142 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	38,726	$7,252,604
2	ABVX	Abivax S.A.	44,256	$5,897,553
3	COGT	Cogent Biosciences, Inc.	138,272	$5,351,125
4	BMRN	Biomarin Pharmaceutical Inc	79,933	$4,573,766
5	VKTX	Viking Therapeutics, Inc.	112,736	$4,397,831
6	EWTX	Edgewise Therapeutics, Inc.	69,441	$2,821,387
7	KOD	Kodiak Sciences Inc.	56,052	$2,183,785
8	IMCR	Immunocore Holdings plc	65,214	$2,070,544

All Filings in CAPR

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$20,010	831	0.0%	Call	Sole	2026-08-07
2026-06-30	$32,652	1,356	-14.1%	Put	Sole	2026-08-07
2026-03-31	$605,963	19,933	-61.3%	Shares	Sole	2026-05-12
2026-03-31	$47,970	1,578	+791.5%	Put	Sole	2026-05-12
2026-03-31	$25,262	831	+37.4%	Call	Sole	2026-05-12
2025-12-31	$1,485,741	51,481	—	Shares	Sole	2026-02-17
2024-12-31	$8,349	605	—	Call	Other	2025-02-14
2024-12-31	$2,442	177	—	Put	Other	2025-02-14
No filing history on record for this holder in this stock.